We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
Cap. Flow
-$111M
Cap. Flow %
-7.32%
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$25.8M
2
AB icon
AllianceBernstein
AB
+$20.1M
3
HES
Hess
HES
+$17.1M
4
BIDU icon
Baidu
BIDU
+$16.3M
5
TGTX icon
TG Therapeutics
TGTX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.94%
2 Consumer Discretionary 9.33%
3 Financials 7.76%
4 Industrials 6.88%
5 Materials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STGW icon
76
Stagwell
STGW
$2.13B
$4.28M 0.28%
950,000
+200,000
+27% +$1.01M
ABEO icon
77
Abeona Therapeutics
ABEO
$362M
$4.26M 0.28%
750,000
+75,000
+11% +$427K
C icon
78
Citigroup
C
$221B
$4.26M 0.28%
+50,000
New +$3.61M
ALDX icon
79
Aldeyra Therapeutics
ALDX
$90.5M
$4.14M 0.27%
1,080,000
+604,000
+127% +$1.56M
SBLK icon
80
Star Bulk Carriers
SBLK
$3.19B
$3.88M 0.26%
225,000
-75,000
-25% -$1.17M
IBIT icon
81
iShares Bitcoin Trust
IBIT
$46.3B
$3.86M 0.25%
63,000
-47,000
-43% -$2.63M
IAG icon
82
IAMGOLD
IAG
$8.21B
$3.75M 0.25%
+510,000
New +$3.57M
TVRD
83
Tvardi Therapeutics
TVRD
$19.5M
$3.63M 0.24%
+176,030
New +$4.16M
NE icon
84
Noble Corp
NE
$6.51B
$3.61M 0.24%
136,000
-79,000
-37% -$1.9M
SLNO
85
DELISTED
Soleno Therapeutics
SLNO
$3.52M 0.23%
42,000
-8,000
-16% -$599K
PRAX icon
86
PUT
Praxis Precision Medicines
PRAX
$8.28B
$3.12M 0.21%
74,300
-20,000
-21% -$762K
HDSN
87
Hudson Technologies
HDSN
$259M
$3.04M 0.2%
375,000
-27,583
-7% -$189K
VTOL icon
88
Bristow Group
VTOL
$1.33B
$2.91M 0.19%
+88,133
New +$2.66M
IMTX icon
89
Immatics
IMTX
$1.17B
$2.91M 0.19%
540,000
-75,000
-12% -$372K
GSAT icon
90
Globalstar
GSAT
$10.9B
$2.9M 0.19%
123,000
-8,012
-6% -$161K
HCC icon
91
Warrior Met Coal
HCC
$4.14B
$2.8M 0.18%
61,000
-4,000
-6% -$186K
CDLX icon
92
Cardlytics
CDLX
$23.2M
$2.71M 0.18%
165,000
+10,000
+6% +$173K
HHH icon
93
Howard Hughes
HHH
$3.89B
$2.7M 0.18%
40,000
-80,000
-67% -$5.47M
NVGS icon
94
Navigator Holdings
NVGS
$1.35B
$2.69M 0.18%
190,000
PANL icon
95
Pangaea Logistics
PANL
$487M
$2.66M 0.17%
565,000
-44,990
-7% -$200K
DDI
96
DoubleDown Interactive
DDI
$580M
$2.63M 0.17%
+275,000
New +$2.7M
RNAC icon
97
Cartesian Therapeutics
RNAC
$233M
$2.28M 0.15%
219,000
+69,000
+46% +$735K
IVVD icon
98
Invivyd
IVVD
$167M
$2.2M 0.14%
3,070,000
+70,000
+2% +$49.7K
IFRX icon
99
InflaRx
IFRX
$247M
$1.96M 0.13%
2,475,000
-150,000
-6% -$177K
PM icon
100
Philip Morris
PM
$294B
$1.82M 0.12%
10,000
-150,000
-94% -$25.8M

Similar funds

683 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.

  • 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
  • 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
  • 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
  • 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
  • 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
  • 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
  • 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.

Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.